VALVOLINE INC. Research and Development Expense
VALVOLINE INC. (VVV) reported Research and Development Expense of $15.00 million for the 12-month period ending 2021-09-30, per its 10-K filed 2021-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2021-11-19
- VALVOLINE INC. research and development expense for fiscal 2021 was $15.00M, a 15.38% increase from fiscal 2020.
- VALVOLINE INC. research and development expense for fiscal 2020 was $13.00M, a 0.00% change from fiscal 2019.
- VALVOLINE INC. research and development expense for fiscal 2019 was $13.00M, a 7.14% decline from fiscal 2018.
- VALVOLINE INC. research and development expense for fiscal 2018 was $14.00M, a 7.69% increase from fiscal 2017.
| Period end | Research and Development Expense 12 month |
|---|---|
| 2021-09-30 | $15.00M 10-K · filed 2021-11-19 |
| 2020-09-30 | $13.00M 10-K · filed 2021-11-19 |
| 2019-09-30 | $13.00M 10-K · filed 2021-11-19 |
| 2018-09-30 | $14.00M 10-K · filed 2020-11-24 |
| 2017-09-30 | $13.00M 10-K · filed 2019-11-22 |
| 2016-09-30 | $13.00M 10-K · filed 2018-11-21 |
| 2015-09-30 | $11.00M 10-K · filed 2017-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUAKER CHEMICAL CORP (KWR) | United States | $2.747B | 27.94 |